|
⚲
|
| Keyboard |
| Fabbio Patrick
✚
|
|
|---|---|
| CIK # | 0001658859 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001658859] | |
| 4 | [0001658859] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| BeyondSpring Inc | |
| Fabbio Patrick | |
| Proteon Therapeutics Inc | |
| Rafael Holdings Inc | |
| Progenics Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Proteon Therapeutics Inc TARA
Common Stock
|
2026-01-26 | Tax withheld | 3,261 | $6.67 | 21,751 |
|
Proteon Therapeutics Inc TARA
Common Stock
|
2026-01-20 | Tax withheld | 3,063 | $5.60 | 17,153 |
|
Proteon Therapeutics Inc TARA
Common Stock
|
2026-01-16 | Grant | 28,000 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2026-01-16 | Grant | 175,000 | $0.00 | |
|
BeyondSpring Inc BYSI
Stock Options (right to buy) · derivative
|
2025-04-21 | Grant | 23,793 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Common Stock
|
2025-01-24 | Grant | 23,500 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2025-01-24 | Grant | 140,000 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Common Stock
|
2025-01-21 | Tax withheld | 3,061 | $4.76 | 14,570 |
|
Proteon Therapeutics Inc TARA
Common Stock
|
2024-01-19 | Grant | 22,000 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2024-01-19 | Grant | 131,000 | $0.00 | |
|
Proteon Therapeutics Inc TARA
Stock Option (Right to Buy) · derivative
|
2023-01-30 | Grant | 300,000 | $0.00 | |
|
Rafael Holdings Inc RFL
Class B Common Stock, par value $.01 per share
|
2022-12-21 | Tax withheld | 27,928 | $1.76 | 49,153 |
|
Rafael Holdings Inc RFL
Class B Common Stock, par value $.01 per share
|
2022-02-01 | Grant | 363,103 | $0.00 | |
|
Rafael Holdings Inc RFL
Employee Stock Option (right to buy) · derivative
|
2021-09-17 | Grant | 105,602 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2020-03-02 | Grant | 82,214 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2019-03-01 | Grant | 90,750 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2018-03-01 | Grant | 94,875 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2017-03-01 | Grant | 82,500 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (right to buy) · derivative
|
2016-03-01 | Grant | 82,500 | $4.52 | 372,900 |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (right to buy) · derivative
|
2015-12-01 | Grant | 125,000 | $6.77 | 846,250 |